Doctor profile · Federal record

Dr. Steven Newman, MD

Medical Oncology Physician (CMS: Internal Medicine) · Hematology (Internal Medicine) Physician · Naples, FL

  • NPI 1750370755
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 49 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3530 Kraft RD Ste 300
Naples, FL 341055020
(239) 353-6636
fax (239) 354-1865
Mailing address
Po Box 102222
Atlanta, GA 303682222

Credentials & registration

NPPES · NUCC
NPI registered
October 2005 — 21 yrs on file
Profile last updated
February 4, 2026
Year of graduation
1977 — 49 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Florida #ME113767
Medicaid
FL #006569600

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750370755. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
482,715
Distinct HCPCS
10
Medicare allowed
$7,178,077
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 128,520 145 $1
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram 85,020 41 $0
J9271 Injection, pembrolizumab, 1 mg 50,800 42 $54
J0185 Injection, aprepitant, 1 mg 35,620 66 $2
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 23,670 89 $7
J0897 Injection, denosumab, 1 mg 22,200 155 $23
J9267 Injection, paclitaxel, 1 mg 15,956 24 $0
J9263 Injection, oxaliplatin, 0.5 mg 14,320 15 $0
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 11,796 29 $45
J9173 Injection, durvalumab, 10 mg 11,028 13 $78

In context: peer comparison

Among 8 peers in Naples Medical Oncology Physician, average services per provider: 5,004. This provider delivers 96× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,580
Transactions
147
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 21 $406.54
Merck Sharp & Dohme LLC 14 $356.05
Pfizer INC. 12 $334.00
Janssen Biotech, INC. 17 $290.27
E.R. Squibb & Sons, L.L.C. 15 $284.00
AstraZeneca Pharmaceuticals Lp 8 $260.28
Eisai INC. 5 $202.06
Gilead Sciences, INC. 9 $200.52
Regeneron Healthcare Solutions, INC. 7 $197.16
Incyte Corporation 9 $161.51
GlaxoSmithKline, LLC. 7 $155.34
Alexion Pharmaceuticals, INC. 7 $149.18
Motiva USA, LLC 1 $147.91
Bayer Healthcare Pharmaceuticals INC. 10 $146.25
Takeda Pharmaceuticals U.S.A., INC. 5 $124.36

By nature of payment

Food and Beverage
$4,380
Education
$200

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,267
Patients
472
Total drug cost
$3,958,946
Drug Type Claims Patients Total cost
Anastrozole Generic 212 75 $8,225
Ondansetron Odt (Ondansetron) Brand 164 102 $2,961
Revlimid (Lenalidomide) Brand 129 22 $2,392,500
Xarelto (Rivaroxaban) Brand 124 40 $150,398
Acyclovir Generic 70 23 $1,354
Letrozole Generic 70 25 $2,052
Hydroxyurea Generic 69 24 $3,819
Dexamethasone Generic 64 42 $1,821
Prednisone Generic 63 34 $714
Gabapentin Generic 59 18 $812

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Steven Newman's medical specialty?
Dr. Steven Newman practices Medical Oncology Physician in Naples, FL.
Where does Dr. Steven Newman practice?
Dr. Steven Newman practices at 3530 Kraft RD Ste 300, Naples, FL 341055020. Office phone: 2393536636.
What is Dr. Steven Newman's NPI?
Dr. Steven Newman's National Provider Identifier (NPI) is 1750370755, issued by NPPES.
Does Dr. Steven Newman accept Medicare assignment?
Yes. Dr. Steven Newman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Steven Newman commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.